DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.59+0.21 (+2.51%)
Close on Nov 18, 2026Market cap $463.22MP/E –Yield –
DiaMedica Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
DiaMedica Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$31.54M. For fiscal 2025 it was -$29.10M. The highest annual figure on record is -$3.92M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.10M | – |
| FY2024 | Dec 31, 2024 | -$22.10M | – |
| FY2023 | Dec 31, 2023 | -$18.75M | – |
| FY2022 | Dec 31, 2022 | -$11.59M | – |
| FY2021 | Dec 31, 2021 | -$12.27M | – |
| FY2020 | Dec 31, 2020 | -$9.23M | – |
| FY2019 | Dec 31, 2019 | -$9.10M | – |
| FY2018 | Dec 31, 2018 | -$5.75M | – |
| FY2017 | Dec 31, 2017 | -$3.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.09M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.16M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.44M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.48M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.52M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.66M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.82M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.81M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.10M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.80M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.50M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.89M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.81M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.35M | – |
| Q2 FY2020 | Jun 30, 2020 | -$844.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.98M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.89M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.86M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.03M | – |
| Q1 FY2018 | Mar 31, 2018 | -$967.00K | – |
See a number that looks wrong?